$71.79
0.06%
NYSE, Sep 24, 04:00 pm EDT. Closed.
ISIN
US45688C1071
Symbol
NGVT

Ingevity Corporation Target price 2026 - Analyst rating & recommendation

Ingevity Corporation Classifications & Recommendation

Buy
89%
Hold
11%

Ingevity Corporation Price Target

Target Price $93.84
Price $71.79
Potential
Number of Estimates 5
5 Analysts have issued a price target Ingevity Corporation 2027 . The average Ingevity Corporation target price is $93.84. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 8 Analysts recommend Ingevity Corporation to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ingevity Corporation stock has an average upside potential 2027 of . Most analysts recommend the Ingevity Corporation stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 1.17 1.14
2.71% 2.71%
EBITDA Margin 25.54% 35.23%
3.71% 37.94%
Net Margin -14.31% 16.59%
60.09% 215.92%

5 Analysts have issued a sales forecast Ingevity Corporation 2026 . The average Ingevity Corporation sales estimate is

$1.1b
unlock
. This is
2.09% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.2b 1.78%
unlock
, the lowest is
$1.1b 6.66%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $1.2b 2.71%
2026
$1.1b 2.71%
unlock
2027
$1.2b 1.41%
unlock
2028
$1.2b 2.08%
unlock

5 Analysts have issued an Ingevity Corporation EBITDA forecast 2026. The average Ingevity Corporation EBITDA estimate is

$400m
unlock
. This is
28.26% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$414m 32.60%
unlock
, the lowest is
$382m 22.50%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $298m 6.31%
2026
$400m 34.20%
unlock
2027
$422m 5.35%
unlock
2028
$438m 3.79%
unlock

EBITDA Margin

2025 25.54% 3.71%
2026
35.23% 37.94%
unlock
2027
36.60% 3.89%
unlock
2028
37.21% 1.67%
unlock

5 Ingevity Corporation Analysts have issued a net profit forecast 2026. The average Ingevity Corporation net profit estimate is

$189m
unlock
. This is
249.09% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$200m 270.76%
unlock
, the lowest is
$174m 222.26%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-167m 61.17%
2026
$189m 212.81%
unlock
2027
$213m 12.81%
unlock
2028
$240m 12.71%
unlock

Net Margin

2025 -14.31% 60.09%
2026
16.59% 215.92%
unlock
2027
18.46% 11.27%
unlock
2028
20.38% 10.40%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -4.61 5.47
61.06% 218.66%
P/E 13.13
EV/Sales 3.14

5 Analysts have issued a Ingevity Corporation forecast for earnings per share. The average Ingevity Corporation EPS is

$5.47
unlock
. This is
257.52% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$5.81 279.74%
unlock
, the lowest is
$5.05 230.07%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-4.61 61.06%
2026
$5.47 218.66%
unlock
2027
$6.17 12.80%
unlock
2028
$6.95 12.64%
unlock

P/E ratio

Current 46.92 595.44%
2026
13.13 72.02%
unlock
2027
11.64 11.35%
unlock
2028
10.33 11.25%
unlock

Based on analysts' sales estimates for 2026, the Ingevity Corporation stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.08 23.20%
2026
3.14 2.06%
unlock
2027
3.10 1.39%
unlock
2028
3.04 2.04%
unlock

P/S ratio

Current 2.13 37.13%
2026
2.17 2.14%
unlock
2027
2.14 1.39%
unlock
2028
2.10 2.04%
unlock

Current Ingevity Corporation Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
➜
Locked
Locked Feb 27 2026
Wells Fargo
Locked
➜
Locked
Locked Jan 29 2026
Wells Fargo
Locked
➜
Locked
Locked Dec 19 2025
BMO Capital
Locked
➜
Locked
Locked Dec 10 2025
Wells Fargo
Locked
➜
Locked
Locked Nov 12 2025
BMO Capital
Locked
➜
Locked
Locked Sep 05 2025
BMO Capital
Locked
➜
Locked
Locked Aug 07 2025
Analyst Rating Date
Locked
Wells Fargo:
Locked
➜
Locked
Feb 27 2026
Locked
Wells Fargo:
Locked
➜
Locked
Jan 29 2026
Locked
Wells Fargo:
Locked
➜
Locked
Dec 19 2025
Locked
BMO Capital:
Locked
➜
Locked
Dec 10 2025
Locked
Wells Fargo:
Locked
➜
Locked
Nov 12 2025
Locked
BMO Capital:
Locked
➜
Locked
Sep 05 2025
Locked
BMO Capital:
Locked
➜
Locked
Aug 07 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today